VenoStent
Manufacturing · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2450 Holcombe Blvd, Houston, Texas, 7702...Phone Number
(832) 429-5362Website
www.venostent.comRevenue
$12.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About VenoStent
Venostent is an biomaterial platform and medical device company that has developed a shape memory polymer stent to help reduce venous access failures in hemodialysis patients. Venostent is headquartered in Nashville, Tennessee, United States.Explore more
VenoStent Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is VenoStent your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if VenoStent has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when VenoStent launches new products
Funding: Get notified immidiatlly once VenoStent has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if VenoStent is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at VenoStent
Earning: See what the market has to say on VenoStent recently announced quarterly report
Click to see if VenoStent had a recent Job posting/layoffs
VenoStent, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to VenoStent
Compare insights from companies similar to VenoStent, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
VenoStent is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
VenoStent is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about VenoStent.
VenoStent financials insights
Gather financial insights about VenoStent, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Other Financing Round
$2.2M
2024
Series A
$20M
2026
Debt
$10M
VenoStent Tech Stack
A closer look at the technologies used by VenoStent
Most Recent Scoops
Funding
Funding
Funding
Project
Spending/Investment, Funding
Funding
Funding
Funding
Funding
VenoStent News & Media
VenoStent Completes $20 Million Series A with $4 Million Investment from Norwest Venture Partners
Company Builds on Momentum with New $3.6 Million NIH SBIR Grant to Fund U.S. Clinical Trial of Breakthrough Medical Device Showing Promise in Improving Dialysis Patient Outcomes HOUSTON, June 27, 2024 /PRNewswire/ -- VenoStent, Inc., a clinical-stage medical device company developing a...VenoStent Closes $16M Series A Financing
VenoStent, Inc., a Houston, TX-based clinical-stage, venture-backed, therapeutic medical device company developing bioabsorbable wraps to improve outcomes for hemodialysis patients, completed a $16M Series A financing. The round was led by Good Growth Capital and IAG Capital Partners, with participation from TMC Venture Fund, SNR, Baylor Angel Network / Affinity Fund, Creative Ventures, Cowtown Angels, Alumni Ventures, and other angel investors. The company […] The post VenoStent Closes $16M SerVenoStent Embarks on Clinical Trial to Improve Success Rate of Vascular Surgery Outcomes
HOUSTON--(BUSINESS WIRE)--VenoStent, Inc., a clinical-stage tissue engineering company developing tunable, bioabsorbable, smart polymer wraps to fundamentally transform the efficacy of the five million vascular surgeries performed each year, announces successful enrollment in its initial feasibility clinical trial. The clinical trial is testing the safety and efficacy of its 3D-printed bioabsorbable wraps in humans, a new methodology to improve surgical outcomes for hemodialysis patients. “We aVenoStent raises $2.2 million to begin clinical trials
Founded by two Vanderbilt University graduates, VenoStent's product helps patients with end-stage renal disease.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding VenoStent
Sign Up For FreeTo access detailed company insights
Venostent is an biomaterial platform and medical device company that has developed a shape memory polymer stent to help reduce venous access failures in hemodialysis patients. Venostent is headquartered in Nashville, Tennessee, United States.... Read More
